ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 1.613
EU - Europa 1.566
AS - Asia 736
SA - Sud America 17
AF - Africa 8
OC - Oceania 2
Totale 3.942
Nazione #
US - Stati Uniti d'America 1.593
IT - Italia 613
SG - Singapore 345
RU - Federazione Russa 233
DE - Germania 227
IE - Irlanda 198
HK - Hong Kong 172
SE - Svezia 104
ID - Indonesia 85
CN - Cina 67
GB - Regno Unito 62
FI - Finlandia 34
IN - India 21
NL - Olanda 19
CA - Canada 18
FR - Francia 17
BR - Brasile 15
CZ - Repubblica Ceca 13
ES - Italia 11
PH - Filippine 8
IR - Iran 6
PK - Pakistan 6
CH - Svizzera 5
TR - Turchia 5
IL - Israele 4
PT - Portogallo 4
UA - Ucraina 4
VN - Vietnam 4
BD - Bangladesh 3
MA - Marocco 3
PL - Polonia 3
RO - Romania 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
IQ - Iraq 2
LT - Lituania 2
MK - Macedonia 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
AT - Austria 1
BE - Belgio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
TH - Thailandia 1
TW - Taiwan 1
Totale 3.942
Città #
Ann Arbor 345
Singapore 300
Dublin 188
Frankfurt am Main 171
Hong Kong 171
Milan 147
Chandler 124
Ashburn 121
New York 113
Santa Clara 105
Jakarta 73
Fairfield 42
Rome 41
Princeton 40
London 31
Wilmington 29
Seattle 27
Bologna 26
Altamura 25
Helsinki 25
Boardman 24
Munich 24
Perugia 21
Verona 20
Parma 19
Lawrence 18
Woodbridge 17
San Diego 15
Washington 15
Florence 14
Houston 14
Shanghai 14
Cambridge 13
Toronto 10
Palermo 9
Pavia 9
Phoenix 9
Lappeenranta 8
Brno 7
Slough 7
Andover 6
Assago 6
Beijing 6
Brescia 6
Chicago 6
Guangzhou 6
Madrid 6
Monza 6
Naples 6
Osasco 6
Berlin 5
Boulogne-Billancourt 5
Carate Brianza 5
Hyderabad 5
Moscow 5
Prague 5
Pune 5
São Paulo 5
Amsterdam 4
Bergamo 4
Canelli 4
Hangzhou 4
Kocaeli 4
Los Angeles 4
Ottawa 4
Padova 4
Tanza 4
Bari 3
Cesena 3
Cutro 3
Dallas 3
Durg 3
Ferrara 3
Giv‘atayim 3
Huizen 3
Iasi 3
Lissone 3
Lummi Island 3
Magenta 3
Melzo 3
Messina 3
Norwalk 3
Nuremberg 3
Osimo 3
Paris 3
Piacenza 3
Pisa 3
Québec 3
Ravenna 3
Redmond 3
Shenyang 3
Triuggio 3
Wolfsburg 3
Aarhus 2
Ambāla 2
Ancona 2
Anguillara Sabazia 2
Barra Mansa 2
Basel 2
Beni Mellal 2
Totale 2.659
Nome #
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 334
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 162
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 161
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 157
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 127
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 127
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 113
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 112
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 106
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 96
A Multidatabase study of trajectories of antidepressant use in Italy 94
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 84
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 83
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 83
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 79
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 70
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 66
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 63
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 60
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 59
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 58
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 57
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 57
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 57
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 56
Azithromycin use and covid-19: a real-world observational study. 55
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 52
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 52
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 50
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 49
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 49
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 48
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 47
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 46
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 45
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 44
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 40
Epidemiology of SLE in Italy: an observational study using a primary care database 39
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 38
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 36
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 34
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 34
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 33
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 32
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 31
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 31
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 31
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 30
Editorial: Overcoming boundaries in public health: Advances in international and global health 30
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 28
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 28
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 28
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 28
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 28
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 27
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 27
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 27
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 27
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 27
The Burden of Chronic Heart Failure in Primary Care in Italy 27
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 27
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 26
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 26
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 26
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 25
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 25
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 25
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 25
Diabetes is associated with decreased migraine risk: A nationwide cohort study 24
Drug-induced Kounis syndrome: A matter of pharmacovigilance 24
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 23
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 23
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 23
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 23
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 23
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 22
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 19
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 16
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 10
Totale 4.234
Categoria #
all - tutte 26.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 6 1 2
2020/2021330 0 4 7 7 37 68 31 34 33 34 30 45
2021/2022451 51 44 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20251.252 173 332 133 189 287 138 0 0 0 0 0 0
Totale 4.234